Earnings Feed
Start Free
BrightSpring Health Services, Inc.·4

Mar 6, 7:45 PM ET

ROUSSEAU JON B 4

Research Summary

AI-generated summary

Updated

BrightSpring CEO Jon B. Rousseau Sells 220,000 Shares

What Happened
Jon B. Rousseau, Chairman, President and Chief Executive Officer of BrightSpring Health Services (BTSG), exercised 220,000 options and then sold 220,000 shares on March 4, 2026. The options were exercised at $6.37 per share (cost ≈ $1,401,400) and the shares were sold in a registered offering at $41.15 per share (proceeds ≈ $9,053,000). In addition, the filing reports new equity awards: RSUs granted on March 5, 2026 and performance-based awards that vested after performance conditions were satisfied.

Key Details

  • Primary transactions: exercised 220,000 options @ $6.37 (acquired) and sold 220,000 shares @ $41.15 (disposed) on 2026-03-04. Sale proceeds ≈ $9,053,000; exercise cost ≈ $1,401,400. (Footnote F1: sale was pursuant to a registered public offering closed Mar 4, 2026 at $41.15, before underwriting discounts/commissions.)
  • Grants recorded: 186,845 RSUs granted on 2026-03-05 (vest in 12 equal quarterly installments beginning 4/25/2026) (Footnote F2). Additional derivative awards/performance-option vesting reported on 3/4–3/5 (see F4–F6).
  • Performance options: previously awarded performance-based options vested after performance conditions were satisfied on March 3, 2026; those options are fully vested (F4, F5).
  • Reporting/ownership notes: the filer disclaims beneficial ownership of certain indirectly owned securities except to the extent of a pecuniary interest (F3).
  • Shares owned after the transactions: not specified in the provided summary of this Form 4.
  • Filing timeliness: Form 4 filed 2026-03-06 for transactions on 2026-03-04 — appears to be timely (no late filing flag).

Context
This was a paired exercise-and-sale: the insider exercised options at a low strike and sold the resulting shares in a registered offering the same day. The filing also reflects new RSU awards (vesting quarterly) and the vesting of previously granted performance options after performance goals were met. These types of filings are factual disclosures of transactions and awards; they do not by themselves indicate the insider’s broader view of company prospects.